BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2208925)

  • 1. Bone scintigraphy in nasopharyngeal carcinoma.
    Sundram FX; Chua ET; Goh AS; Toh HJ; Khor TH; Chua EJ
    Clin Radiol; 1990 Sep; 42(3):166-9. PubMed ID: 2208925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of skeletal metastases in nasopharyngeal carcinoma after initiation of therapy: should bone scans be used for follow-up?
    Caglar M; Ceylan E; Ozyar E
    Nucl Med Commun; 2003 Dec; 24(12):1231-6. PubMed ID: 14627849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is 18F-FDG PET/CT more reliable than 99mTc-MDP planar bone scintigraphy in detecting bone metastasis in nasopharyngeal carcinoma?
    Yang Z; Zhang Y; Shi W; Zhu B; Hu S; Yao Z; Pan H; Hu C; Zhang Y; Li D
    Ann Nucl Med; 2014 Jun; 28(5):411-6. PubMed ID: 24610681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 99Tcm-MDP and 99Tcm-DPD in pathologic bone lesions. A visual and quantitative comparison.
    Lantto T; Vorne M; Mokka R; Vähätalo S
    Acta Radiol; 1987; 28(5):631-3. PubMed ID: 2960361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of bone scanning in detection of subclinical bone metastasis in nasopharyngeal carcinoma.
    Sham JS; Tong CM; Choy D; Yeung DW
    Clin Nucl Med; 1991 Jan; 16(1):27-9. PubMed ID: 1999052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
    Ak I; Sivrikoz MC; Entok E; Vardareli E
    Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertrophic pulmonary osteoarthropathy in nasopharyngeal carcinoma: an early sign of pulmonary metastasis.
    Liu RS; Chen YK; Yen SH; Chu YK; Chu LS; Chen KY; Yeh SH
    Nucl Med Commun; 1995 Sep; 16(9):785-9. PubMed ID: 7478412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which diphosphonate for routine bone scintigraphy (MDP, HDP or DPD)?
    Frühling J; Verbist A; Balikdjian D
    Nucl Med Commun; 1986 Jun; 7(6):415-25. PubMed ID: 3748485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staging bone scintigraphy in nasopharyngeal carcinoma.
    Leung SF; Stewart IE; Tsao SY; Metreweli C
    Clin Radiol; 1991 May; 43(5):314-5. PubMed ID: 2036755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of non-staging skeletal scintigraphy in breast cancer.
    Kunkler IH; Merrick MV
    Clin Radiol; 1986 Nov; 37(6):561-2. PubMed ID: 3098492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
    Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
    J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases.
    Limouris GS; Voliotopoulos V; Stavraka A; Vlahos L
    Anticancer Res; 1997; 17(3B):1615-8. PubMed ID: 9179204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 99Tcm-labelled MDP and DMAD bone scanning agents in patients with advanced breast cancer.
    Coleman RE; Meier CA; Rubens RD; Fogelman I
    Nucl Med Commun; 1988 Jul; 9(7):481-5. PubMed ID: 3173907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of the bone marrow imaging agent 99Tcm-phytate in the detection of bone metastases.
    Chang CP; Liu RS; Yu SM; Wynchank S; Chu LS; Shiau HY; Cheng TC
    Nucl Med Commun; 1996 Dec; 17(12):1030-4. PubMed ID: 9004298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrograde analysis of clinical characteristics of bone metastasis in 1,031 cases of preliminarily diagnosed nasopharyngeal carcinoma.
    Zhao CL; Qian GQ; Chen XY; Chen C
    Asian Pac J Cancer Prev; 2014; 15(8):3785-8. PubMed ID: 24870794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases.
    Chang CY; Gill CM; Joseph Simeone F; Taneja AK; Huang AJ; Torriani M; Bredella MA
    Acta Radiol; 2016 Jan; 57(1):58-65. PubMed ID: 25533313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of bone metastases by Tc-99m MDP imaging in patients with stomach cancer.
    Choi CW; Lee DS; Chung JK; Lee MC; Kim NK; Choi KW; Koh CS
    Clin Nucl Med; 1995 Apr; 20(4):310-4. PubMed ID: 7788986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical studies on the detection of bone metastasis in lung cancer by bone scintigraphy].
    Nakano S; Hasegawa Y; Kajita A; Nakamura S; Horai T; Ikegami H; Matuda M; Okamoto N; Nabeshima H; Doi O; Komatubara Y; Ishigami S
    Kaku Igaku; 1983 Feb; 20(1):37-43. PubMed ID: 6308314
    [No Abstract]   [Full Text] [Related]  

  • 19. Radionuclide liver and bone scanning in the evaluation of patients with endometrial carcinoma.
    Mettler FA; Christie JH; Garcia JF; Baldwin MH; Wicks JD; Bartow SA
    Radiology; 1981 Dec; 141(3):777-80. PubMed ID: 6272356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical comparison of bone scintigraphy with 99Tcm-DPD, 99Tcm-HDP and 99Tcm-MDP.
    Bergqvist L; Brismar J; Cederquist E; Darte L; Naversten Y; Palmer J
    Acta Radiol Diagn (Stockh); 1984; 25(3):217-23. PubMed ID: 6236672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.